Michael Yaffe

David H. Koch Professor in Science
Department
Department of Biology
Technology Areas
Biotechnology: Biomedical Devices & Systems, DNA & RNA Editing, Synthetic Biology / Diagnostics: Assays / Therapeutics: Cell Based Therapy, Nucleic Acids, Proteins & Antibodies, Vaccines, Small Molecules / Drug Discovery and Research Tools: Genomics & Proteomics, Antibodies
Impact Areas
Healthy Living

Technologies

Plk1 inhibitor and Microtubule Poison Dual Payload Antibody Drug Conjugates for the Treatment of Cancer

Technology / Case number: #26136
Michael Yaffe / Jesse C Patterson
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Brd4 as a Prognostic Indicator and Modulator of the Cell Response to DNA Damage

Technology / Case number: #15011
Michael Yaffe / Scott Floyd
Technology Areas: Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Sequential Application of Anticancer Drugs Enhance Cell Death by Rewiring Apoptotic Signaling Networks

Technology / Case number: #15616
Paula Hammond / Stephen Morton / Michael Lee / Michael Yaffe
Technology Areas: Biotechnology
Impact Areas: Healthy Living
License

Intra-Tumoral Injection of Cytotoxic Chemotherapy-Treated Tumor Cells in Combination with Systemic Immune Checkpoint Blockade for Cancer Treatment

Technology / Case number: #21498H
Darrell J Irvine / Lauren Milling / Ganapathy Sriram / Michael Yaffe
Technology Areas: Diagnostics / Therapeutics
Impact Areas: Healthy Living
License

A Modified Viscoelastic Assay Rapidly Unmasks Pathological Fibrinolysis Phenotypes in a Wide Spectrum of Human Diseases

Technology / Case number: #19496J
Michael Yaffe / Hunter Moore / Ernest Moore / Christopher Barrett
Technology Areas: Biotechnology / Diagnostics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up